HLS THERAPEUTICS INC by HLS Therapeutics Inc. Analyst Price Targets - Benzinga

HLS THERAPEUTICS INC by HLS Therapeutics Inc.

HLTRFOTCPK

Trade with Public

Trade with Public

$2.64

N/A

At close: Sep 1, 5:00 PM EST

Overview NewsPrice TargetsFinancials Sentiment Compare

HLS THERAPEUTICS INC by HLS Therapeutics Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for HLS THERAPEUTICS INC by HLS Therapeutics Inc. (HLTRF).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Hold

Consensus RatingMarket Perform# Analysts1Avg. Consensus PT$5Upside to Avg. PT+89.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Mar 18, 2024	Raymond James	Rahul Sarugaser	PT Cut	Market Perform	$7→$5

Analyst Ratings News

PRO
Raymond James Maintains Market Perform on HLS Therapeutics, Lowers Price Target to $5

Raymond James analyst Rahul Sarugaser maintains HLS Therapeutics (OTC:HLTRF) with a Market Perform and lowers the price target from $6.5 to $5.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021

Benzinga Insights

PRO
Raymond James Downgrades HLS Therapeutics to Market Perform

Raymond James downgrades HLS Therapeutics (OTC:HLTRF) from Outperform to Market Perform.

Benzinga Newsdesk